Position in ARDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$288,124
-$9,301,009 QoQ
Shares Held
56,495
-96.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#125
of 250 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. ARDX ranks #235 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in ARDX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288,124 | 56,495 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $9,589,133 | 1,600,857 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $30,249,764 | 5,188,639 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $49,276,160 | 8,943,042 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $44,102,555 | 11,250,652 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $41,164,501 | 8,383,809 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $582,132 | 114,819 | Shares | Other | 2025-02-13 | |
| 2024-03-31 | $1,974,401 | 270,466 | Shares | Other | 2024-05-15 | |
| 2023-03-31 | $312,470 | 65,234 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $2,118,709 | 743,407 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $133,042 | 111,800 | Shares | Other | 2022-11-14 | |
| 2021-06-30 | $25,380,591 | 3,348,363 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $20,573,205 | 3,107,735 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $21,269,937 | 3,287,471 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $17,244,386 | 3,284,645 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $22,893,609 | 3,308,325 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $18,951,555 | 3,333,607 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||